Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Pharmaceutics|May 27, 2026
Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive TractAn Le, Guru R Valicherla, Junmei Zhang, et al.Psychopharmacology|September 15, 2004
Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influencesFrancis E Lotrich, Robert Bies, Matthew F Muldoon, et al.Pharmaceutical Research|August 12, 2009
Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study designGregor Bender, James Gosset, Jeff Florian, et al.Clinical Pharmacology and Therapeutics|February 2, 2026
Advancing Maternal Health with Long-Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging TechnologiesRachel K Scott, Sharon Nachman, Ethel D Weld, et al.Pharmaceutics|July 28, 2026
Determining Critical Physiological and Drug Specific Parameters for Enhancing a Physiologically Based Pharmacokinetics Model for the Female Reproductive TractAn Le, Riyazuddin Mohammed, Junmei Zhang, et al.Journal of Consulting and Clinical Psychology|January 28, 2009
Citalopram intervention for hostility: results of a randomized clinical trialThomas W Kamarck, Roger F Haskett, Matthew Muldoon, et al.CPT: Pharmacometrics & Systems Pharmacology|February 28, 2023
Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary reportMing-Liang Tan, Sajeev Chandran, Rebeka Jereb, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 28, 2024
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimizationXinnong Li, Mark Sale, Keith Nieforth, et al.Clinical Pharmacology and Therapeutics|December 1, 2023
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-Effect Model Selection ToolboxXinnong Li, Mark Sale, Keith Nieforth, et al.British Journal of Cancer|February 11, 2020
A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinomaChristos Fountzilas, Medhavi Gupta, Sunyoung Lee, et al.Pageof 5